Allergy Management - Cow & Gate pepti-junior and infasoy

Cow & Gate pepti-junior is a whey-based hydrolysate with medium chain triglyceride (MCT) oil suitable from birth.

It is prescribable for the management of malabsorption and multiple food intolerances and for the dietary management of conditions such as protracted diarrhoea, severe food intolerance, short bowel syndrome, cystic fibrosis, inflammatory bowel disease and severe protein-energy malnutrition.

More palatable than a casein hydrolysate^1,2.

Contains LCPs for brain, eye and nervous system development^3-5, as well as nucleotides which are important in cell division, protein synthesis and immune function^6,7.

Suitable as a sole source of nutrition for infants and as a principal source of nourishment, with other foods, for babies over 6 months and children.

Cow & Gate pepti-junior is available in: 450g tin

Click here to download a datacard for Cow & Gate pepti-junior that includes full ingredients listings and nutritional values


Cow & Gate infasoy is a soya infant formula, suitable as a sole source of nutrition from birth* and as a cows’ milk replacement for infants and older children.

It is prescribable for cows’ milk allergy/intolerance, galactosaemia, galactokinase deficiency and lactose intolerance. It should only be used on the advice of Healthcare Professionals for those with cows’ milk protein allergy/intolerance.

Good source of calcium, with a calcium:phosphorus ratio that aids bone mineralisation ^8.

Recommended essential fatty acid ratio⁹.

Approved by the Vegetarian Society.

Cow & Gate infasoy is available in: 900g EaZypack.


Click here to download a datacard for Cow & Gate infasoy that includes full ingredients listings and nutritional values

*Chief Medical Officer (CMO) statement: The CMO has reiterated advice that soya-based infant formulas should not be used as the first choice for the management of infants with proven cows’ milk sensitivity, lactose intolerance, galactokinase deficiency and galactosaemia. Soya-based formulas should only be used in exceptional circumstances to ensure adequate nutrition.

References

1. Pedrosa M et al. Palatability of hydrolysates and Other substitution formulas for cows’ milk-allergic children: a comparative study of taste, smell, and texture evaluated by healthy volunteers. J Investig Allergol Clin Immunol 2006;16(6):351-6.
2. Mabin DC et al. Nutritional content of a few foods diet in atopic dermatitis. Arch Dis Child 1995;73(3):208-10.
3. Birch EE et al. Visual acuity and the essentiality of docosahexaenoic acid and archidonic acid in the diet of term infants. Pediatr Res 1998;44(2):201-209.
4. Birch EE et al. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neuro 2000;42(3):174-81.
5. Willats et al. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 1998;352(9129):688-91.
6. Maldonado J et al. The influence of dietary nucleotides on humoral and cell immunity in the neonate and lactating infant. Early Hum Dev 2001;65 (Suppl); S69-74.
7. Pickering LK et al. Modulation of the immune system by human milk and infant formula containing nucleotides. Pediatrics 1998;101(2):242-9.
8. Scientific Committee on Food. Report of the SCF on the revision of the essential requirements for infant formulae and follow-on formulae. Brussels: European Commission 2003.
9. Makrides M et al. A randomized trial of different ratios of linoleic to alpha-linolenic acid in the diet of term infants: effects on visual function and growth. Am J Clin Nutr 2000;7(1):120-9